課程名稱 |
生技製藥二 Pharmaceutical Biotechnology (Ⅱ) |
開課學期 |
101-1 |
授課對象 |
學程 分子醫藥學程 |
授課教師 |
|
課號 |
PHARM5007 |
課程識別碼 |
423 U0540 |
班次 |
|
學分 |
1 |
全/半年 |
半年 |
必/選修 |
選修 |
上課時間 |
星期一6(13:20~14:10) |
上課地點 |
基1203 |
備註 |
必須同時修習生技製藥一 總人數上限:18人 |
Ceiba 課程網頁 |
http://ceiba.ntu.edu.tw/1011biopharm2 |
課程簡介影片 |
|
核心能力關聯 |
核心能力與課程規劃關聯圖 |
課程大綱
|
為確保您我的權利,請尊重智慧財產權及不得非法影印
|
課程概述 |
This is the second part of a half-year survey course aimed to introduce Pharmacy students to various biotechnology-related techniques and their applications in the discovering and manufacturing of biopharmaceuticals as well as biomedical research. The course begins with a general introduction to the physicochemical characteristics, pharmacology, and formulation of proteins and the basics in protein production and manufacturing. Since the production, downstream processing, and characterization of biopharmaceuticals are in many aspects very different from conventional small molecular therapeutics, issues relevant to the handling and delivering of those products are also highlighted. Finally, several approved and potential biopharmaceuticals are discussed. Two hours of lecture per week.
|
課程目標 |
To introduce Pharmacy students to various biotechnology-related techniques and their applications in the discovering and manufacturing of biopharmaceuticals as well as biomedical research |
課程要求 |
|
預期每週課後學習時數 |
|
Office Hours |
|
指定閱讀 |
|
參考書目 |
References:
1. (CS) D. J.A. Crommelin, R.D. Sindelar (2002), Pharmaceutical Biotechnology — An Introduction for Pharmacists and Pharmaceutical Scientists, Hardwood Academic Publishers
2. (KM) O. Kayser, R.H. Muller (2004), Pharmaceutical Biotechnology — Drug Discovery and Clinical Applications, Wiley-VCH |
評量方式 (僅供參考) |
No. |
項目 |
百分比 |
說明 |
1. |
Written Report/Oral Presentation |
60% |
|
2. |
Written Exams |
30% |
one final |
3. |
Class Participation |
10% |
|
|
週次 |
日期 |
單元主題 |
第10週 |
11/12 |
Gene Therapy
|
第11週 |
11/19 |
Hybridoma Technology & Applications in the Production of Monoclonal Antibodies
|
第12週 |
11/26 |
Biotechnologically Derived Therapeutic Proteins: insulin, monoclonal antibodies |
第13週 |
12/03 |
Vaccines |
第14週 |
12/10 |
Recombinant Thrombolytic Agents, Recombinant Coagulation Factors |
第15週 |
12/17 |
Biotechnology Products in the Pipeline |
第16週 |
12/24 |
Group Discussion/Presentation |
第17週 |
12/31 |
Group Discussion/Presentation |
|